|Podcasts|February 11, 2022
Price Transparency Regulations are Accelerating Market Disruption. Are You Prepared?
Author(s)Deloitte LLP
As pricing transparency regulations and COVID-19 accelerate market disruption and changes in consumer behavior demand new engagement models, how can your organization prepare for the powerful shift toward more consumer-centric pricing transparency?
Related Content
Trending on PharmExec
1
Pharmaceutical Executive Daily: Unpacking IRA-Driven Formulary Pressure
2
From Pilot to Profit: How Pharma Leaders Are Scaling AI Across the Drug Lifecycle
3
President Trump Set to Nominate Heidi Overton as FDA Commissioner
4
When Drug Pricing Becomes Trade Policy
5